|
SNX4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
4.18019951986537E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
3.795700E-02 |
| Stage1-vs-Stage3 |
4.260400E-01 |
| Stage1-vs-Stage4 |
9.457900E-03 |
| Stage2-vs-Stage3 |
1.135730E-02 |
| Stage2-vs-Stage4 |
4.150800E-04 |
| Stage3-vs-Stage4 |
5.954500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.62500000519839E-08 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
2.797400E-01 |
| Caucasian-vs-Asian |
7.048800E-01 |
| AfricanAmerican-vs-Asian |
2.383400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
9.071800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6242562850266E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.65002999999997E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.855800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.098200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.749400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.918800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.032600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.413000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.601100E-04 |
| Classical-VS-Follicular |
9.8816000004831E-07 |
| Classical-VS-Other |
3.537200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.65900004844843E-09 |
| Tall-VS-Other |
3.171200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.821340E-03 |
| Follicular-VS-Normal |
1.23370202942397E-11 |
| Other-VS-Normal |
4.26729984681629E-10 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.169000E-04 |
|
|
